A detailed history of Schonfeld Strategic Advisors LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 89,643 shares of INVA stock, worth $1.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
89,643
Previous 62,903 42.51%
Holding current value
$1.6 Million
Previous $1.03 Million 67.8%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.33 - $20.04 $436,664 - $535,869
26,740 Added 42.51%
89,643 $1.73 Million
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $905,803 - $1.03 Million
62,903 New
62,903 $1.03 Million
Q4 2023

Feb 14, 2024

BUY
$12.32 - $16.27 $584,189 - $771,490
47,418 New
47,418 $760,000
Q1 2023

May 15, 2023

SELL
$10.73 - $13.6 $527,433 - $668,508
-49,155 Reduced 58.19%
35,313 $397,000
Q4 2022

Feb 14, 2023

SELL
$11.8 - $13.78 $739,093 - $863,110
-62,635 Reduced 42.58%
84,468 $1.12 Million
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $1.71 Million - $2.24 Million
147,103 New
147,103 $1.71 Million
Q2 2022

Aug 15, 2022

SELL
$14.32 - $19.88 $531,272 - $737,548
-37,100 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $570,969 - $751,275
37,100 New
37,100 $718,000
Q1 2020

May 15, 2020

SELL
$8.11 - $15.23 $150,862 - $283,308
-18,602 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$10.28 - $14.38 $191,228 - $267,496
18,602 New
18,602 $264,000
Q3 2018

Nov 14, 2018

SELL
$13.63 - $15.7 $691,736 - $796,790
-50,751 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$13.44 - $17.59 $682,093 - $892,710
50,751 New
50,751 $700,000
Q1 2018

May 15, 2018

SELL
$13.8 - $16.99 $1.06 Million - $1.3 Million
-76,780 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$11.73 - $14.75 $354,656 - $445,966
-30,235 Reduced 28.25%
76,780 $1.09 Million
Q3 2017

Nov 14, 2017

BUY
$12.06 - $14.12 $1.29 Million - $1.51 Million
107,015
107,015 $1.51 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.